|
SareninDrug - Sarenin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Saralasin Acetate
Strength -
EQ 0.6MG BASE/ML
Applicant -
PROCTER AND GAMBLE
New Drug Application (NDA) Number -
018009
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co
Sarenin
Liposyn Ii 20% 10%;10% (10gm/100ml) Injectable; Injection
Serevent Eq 0.021mg Base/inh Aerosol, Metered; Inhalation Serevent Eq 0.046mg Base/inh Powder; Inhalation Quadramet 50mci/ml Injectable; Injection Fortovase 200mg Capsule; Oral Invirase Eq 200mg Base Capsule; Oral Invirase Eq 500mg Base Tablet; Oral Sarenin Eq 0.6mg Base/ml Injectable; Injection Liposyn 20% 20% (20gm/100ml) Injectable; Injection Liposyn Ii 10% 5%;5% (5gm/100ml) Injectable; Injection NewDrugInformation |